CJC1295 + Ipamorelin

CJC-1295 and Ipamorelin is a peptide combination therapy designed to stimulate the body's natural production of growth hormone (GH).

CJC-1295 acts as a synthetic analog of growth hormone releasing hormone (GHRH), which stimulates the pituitary gland to release more growth hormone. It works by increasing the amplitude of GH pulses, resulting in sustained elevation of GH levels. This leads to various physiological effects, including increased muscle mass, improved recovery, enhanced fat metabolism, and potential anti-aging benefits.

Ipamorelin, on the other hand, is a selective ghrelin receptor agonist. It stimulates the release of growth hormone by mimicking the action of ghrelin, a hormone that regulates hunger and energy balance. Ipamorelin promotes a gradual and natural increase in GH levels without causing spikes or disrupting the body's natural hormone balance.

When used together, CJC-1295 and Ipamorelin synergistically enhance the release of growth hormone, resulting in amplified effects on muscle growth, fat loss, recovery, and overall well-being. This combination is often utilized in therapeutic settings for individuals seeking to optimize their physical performance, promote healthy aging, and address age-related declines in hormone levels.